Scipreneur
  • HOME
  • NEWS
  • Our Services
    • Submit Your Requirements
  • SCIPRENEURSHIP
  • INNOVATIONS
  • Webinars
  • MOTIVOLOGY
  • QUICK KEYS
  • EVENTS
  • Videos
  • Join our network
  • ABOUT US
  • Policies
    • TERMS and CONDITIONS
    • PRIVACY POLICY
    • DISCLAIMER
    • RETURN POLICY
  • CONTACT US
    • Advertise With Scipreneur

Atezolizumab

FDA Grants Priority Review to Genentech’s Cancer Immunotherapy Tecentriq

May 7, 2018 Scipreneur Private Limited 0

FDA Grants Priority Review to Genentech’s Cancer Immunotherapy Tecentriq By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in combination [..]

QUICK KEYS

previous arrow
next arrow
PlayPause
Slider
Scipreneur
  • Advertise With Scipreneur
  • DISCLAIMER
  • HOME
  • Join our network
  • Our Services
  • PRIVACY POLICY
  • QUICK KEYS
  • RETURN POLICY
  • Submit Your Requirements
  • TERMS and CONDITIONS
  • Videos
  • ABOUT US
  • CONTACT US
Recent
  • 5 Ways to Promote STEM Learning Through Fun Activities for Kids May 17, 2022
  • The Impact of STEM on the Future of the IT Industry May 10, 2022
  • SaaS: What it is and Why it Matters for Your Cybersecurity Strategy? April 8, 2022
  • Why Coding Is Essential To Automate Business? March 8, 2022
  • Is Python Perfect for Startup Businesses? March 1, 2022
Follow Us
Follow ScipreneurFollow on FacebookTweet about this on TwitterFollow on LinkedInPin on PinterestEmail this to someone
Quote of the Day
more Quotes

Copyright © 2022 | WordPress Theme by MH Themes